BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 19085435)

  • 1. Forget-me-nots in the care of children with retinoblastoma.
    Shields CL
    Semin Ophthalmol; 2008; 23(5):324-34. PubMed ID: 19085435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Retinoblatoma: a review].
    Doz F
    Arch Pediatr; 2006 Oct; 13(10):1329-37. PubMed ID: 16930963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
    Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ
    Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
    Shields CL; Ramasubramanian A; Thangappan A; Hartzell K; Leahey A; Meadows AT; Shields JA
    Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodine 125 plaque radiotherapy as salvage treatment for retinoblastoma recurrence after chemoreduction in 84 tumors.
    Shields CL; Mashayekhi A; Sun H; Uysal Y; Friere J; Komarnicky L; Shields JA
    Ophthalmology; 2006 Nov; 113(11):2087-92. PubMed ID: 16949158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoblastoma: clinical features and current concepts in management.
    Watts P
    J Indian Med Assoc; 2003 Aug; 101(8):464-6, 468. PubMed ID: 15071798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
    Brichard B; De Bruycker JJ; De Potter P; Neven B; Vermylen C; Cornu G
    Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoblastoma: a proposal for a multimodal treatment concept for intraocular retinoblastoma in Austria.
    Sovinz P; Urban C; Lackner H; Benesch M; Langmann G
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):22-30. PubMed ID: 16489522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
    Shields CL; Mashayekhi A; Cater J; Shelil A; Ness S; Meadows AT; Shields JA
    Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
    Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
    Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors.
    Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA
    Trans Am Ophthalmol Soc; 2004; 102():35-44; discussion 44-5. PubMed ID: 15747743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical therapeutic efficiency of chemoreduction and local therapy for children with retinoblastoma].
    Qian J; Xue K; Gao YJ; Yuan YF; Shan HD; Bi YW
    Zhonghua Yan Ke Za Zhi; 2010 Apr; 46(4):312-6. PubMed ID: 20654057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diode laser thermotherapy and chemothermotherapy in the treatment of retinoblastoma].
    Lumbroso L; Doz F; Levy C; Dendale R; Vedrenne J; Bours D; Zucker JM; Asselain B; Desjardins L
    J Fr Ophtalmol; 2003 Feb; 26(2):154-9. PubMed ID: 12660589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitreoretinal complications of retinoblastoma treatment.
    Tawansy KA; Samuel MA; Shammas M; Murphree AL
    Retina; 2006 Sep; 26(7 Suppl):S47-52. PubMed ID: 16946679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intraocular retinoblastoma: new therapeutic options].
    Imhof SM; Moll AC; Schouten-van Meeteren AY
    Ned Tijdschr Geneeskd; 2001 Nov; 145(45):2165-70. PubMed ID: 11727614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective review of visual outcome and complications in the treatment of retinoblastoma.
    O'Doherty M; Lanigan B; Breathnach F; O'Meara A; Gallie B; Chan H; O'Keefe M
    Ir Med J; 2005 Jan; 98(1):17-20. PubMed ID: 15782728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basic understanding of current classification and management of retinoblastoma.
    Shields CL; Shields JA
    Curr Opin Ophthalmol; 2006 Jun; 17(3):228-34. PubMed ID: 16794434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and current management of retinoblastoma.
    Balmer A; Zografos L; Munier F
    Oncogene; 2006 Aug; 25(38):5341-9. PubMed ID: 16936756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservative treatments of intraocular retinoblastoma.
    Lumbroso-Le Rouic L; Aerts I; Lévy-Gabriel C; Dendale R; Sastre X; Esteve M; Asselain B; Bours D; Doz F; Desjardins L
    Ophthalmology; 2008 Aug; 115(8):1405-10, 1410.e1-2. PubMed ID: 18222001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.